Diphyllobothriasis medical therapy
|
Diphyllobothriasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diphyllobothriasis medical therapy On the Web |
|
American Roentgen Ray Society Images of Diphyllobothriasis medical therapy |
|
Risk calculators and risk factors for Diphyllobothriasis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2] Furqan M M. M.B.B.S[3]
Overview
Medical Therapy
Praziquantel
Oral praziquantel is available for human use in the United States.
Niclosamide
Niclosamide is NOT available for human use in the United States.
Shown below is a table summarizing the preferred and alternative empiric treatment for Diphyllobothriasis[1]
| Pathogens | Preferred Treatment | Duration of Treatment | Alternative Treatment |
| Diphyllobothrium latum | Praziquantel*
Adults, 5-10 mg/kg orally in a single-dose therapy; the dosage for children is the same. |
Single dose | Niclosamide
Adult 2 gm orally once; children, 50 mg/kg (max 2 gm) orally once. |
- Not FDA-approved for this indication.*
- (Note: praziquantel should be taken with liquids during a meal.)